{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:51:46Z","timestamp":1788871906074,"version":"build-2803163510"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1007\/s00428-020-03011-3","type":"journal-article","created":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T00:04:29Z","timestamp":1609977869000},"page":"21-30","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["Update on genetically defined lung neoplasms: NUT carcinoma and thoracic SMARCA4-deficient undifferentiated tumors"],"prefix":"10.1007","volume":"478","author":[{"given":"Kyriakos","family":"Chatzopoulos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer M.","family":"Boland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,6]]},"reference":[{"key":"3011_CR1","doi-asserted-by":"publisher","first-page":"4135","DOI":"10.1200\/JCO.2004.02.107","volume":"22","author":"CA French","year":"2004","unstructured":"French CA, Kutok JL, Faquin WC, Toretsky JA, Antonescu CR, Griffin CA et al (2004) Midline carcinoma of children and young adults with NUT rearrangement. J Clin Oncol 22:4135\u20134139","journal-title":"J Clin Oncol"},{"key":"3011_CR2","first-page":"3327","volume":"51","author":"I Kubonishi","year":"1991","unstructured":"Kubonishi I, Takehara N, Iwata J, Sonobe H, Ohtsuki Y, Abe T et al (1991) Novel t(15;19)(q15;p13) chromosome abnormality in a thymic carcinoma. Cancer Res 51:3327\u20133328","journal-title":"Cancer Res"},{"key":"3011_CR3","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1097\/00043426-199124000-00011","volume":"13","author":"UR Kees","year":"1991","unstructured":"Kees UR, Mulcahy MT, Willoughby ML (1991) Intrathoracic carcinoma in an 11-year-old girl showing a translocation t(15;19). Am J Pediatr Hematol Oncol 13:459\u2013464","journal-title":"Am J Pediatr Hematol Oncol"},{"key":"3011_CR4","first-page":"304","volume":"63","author":"CA French","year":"2003","unstructured":"French CA, Miyoshi I, Kubonishi I, Grier HE, Perez-Atayde AR, Fletcher JA (2003) BRD4-NUT fusion oncogene: a novel mechanism in aggressive carcinoma. Cancer Res 63:304\u2013307","journal-title":"Cancer Res"},{"key":"3011_CR5","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1111\/pin.12727","volume":"68","author":"CA French","year":"2018","unstructured":"French CA (2018) NUT carcinoma: clinicopathologic features, pathogenesis, and treatment. Pathol Int 68:583\u2013595","journal-title":"Pathol Int"},{"key":"3011_CR6","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1097\/JTO.0000000000000630","volume":"10","author":"WD Travis","year":"2015","unstructured":"Travis WD, Brambilla E, Nicholson AG, Yatabe Y, Austin JHM, Beasley MB et al (2015) The 2015 World Health Organization Classification of Lung Tumors: impact of genetic, clinical and radiologic advances since the 2004 classification. J Thorac Oncol 10:1243\u20131260","journal-title":"J Thorac Oncol"},{"key":"3011_CR7","unstructured":"Travis WD, Brambilla E, Burke AP et al (eds) (2015) WHO Classification of Tumours of the Lung, Pleura, Thymus and Heart, 4th ed. WHO Classification of Tumours2015, IARC Press: Lyon"},{"key":"3011_CR8","doi-asserted-by":"publisher","first-page":"5773","DOI":"10.1158\/1078-0432.CCR-12-1153","volume":"18","author":"DE Bauer","year":"2012","unstructured":"Bauer DE, Mitchell CM, Strait KM, Lathan CS, Stelow EB, L\u00fcer SC et al (2012) Clinicopathologic features and long-term outcomes of NUT midline carcinoma. Clin Cancer Res 18:5773\u20135779","journal-title":"Clin Cancer Res"},{"key":"3011_CR9","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1007\/s00405-018-4882-y","volume":"275","author":"P Giridhar","year":"2018","unstructured":"Giridhar P, Mallick S, Kashyap L, Rath GK (2018) Patterns of care and impact of prognostic factors in the outcome of NUT midline carcinoma: a systematic review and individual patient data analysis of 119 cases. Eur Arch Otorhinolaryngol 275:815\u2013821","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"3011_CR10","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1097\/JTO.0000000000000545","volume":"10","author":"LM Sholl","year":"2015","unstructured":"Sholl LM, Nishino M, Pokharel S, Mino-Kenudson M, French CA, Janne PA et al (2015) Primary pulmonary NUT midline carcinoma: clinical, radiographic, and pathologic characterizations. J Thorac Oncol 10:951\u2013959","journal-title":"J Thorac Oncol"},{"key":"3011_CR11","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.cancergencyto.2010.06.007","volume":"203","author":"CA French","year":"2010","unstructured":"French CA (2010) NUT midline carcinoma. Cancer Genet Cytogenet 203:16\u201320","journal-title":"Cancer Genet Cytogenet"},{"key":"3011_CR12","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.lungcan.2015.10.001","volume":"90","author":"A Harms","year":"2015","unstructured":"Harms A, Herpel E, Pfarr N, Penzel R, Heussel CP, Herth FJ et al (2015) NUT carcinoma of the thorax: case report and review of the literature. Lung Cancer 90:484\u2013491","journal-title":"Lung Cancer"},{"key":"3011_CR13","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1002\/dc.24150","volume":"47","author":"KD Shenoy","year":"2019","unstructured":"Shenoy KD, Stanzione N, Caron JE, Fishbein GA, Abtin F, Lluri G et al (2019) Midline carcinoma expressing NUT in malignant effusion cytology. Diagn Cytopathol 47:594\u2013598","journal-title":"Diagn Cytopathol"},{"key":"3011_CR14","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1097\/JTO.0b013e3181ebaa20","volume":"5","author":"N Fujioka","year":"2010","unstructured":"Fujioka N, French CA, Cameron MJ, Kratzke RA (2010) Long-term survival of a patient with squamous cell carcinoma harboring NUT gene rearrangement. J Thorac Oncol 5:1704\u20131705","journal-title":"J Thorac Oncol"},{"key":"3011_CR15","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1002\/cncy.21761","volume":"124","author":"JA Bishop","year":"2016","unstructured":"Bishop JA, French CA, Ali SZ (2016) Cytopathologic features of NUT midline carcinoma: A series of 26 specimens from 13 patients. Cancer Cytopathol 124:901\u2013908","journal-title":"Cancer Cytopathol"},{"key":"3011_CR16","first-page":"9791208","volume":"2020","author":"L Zhou","year":"2020","unstructured":"Zhou L, Yong X, Zhou J, Xu J, Wang C (2020) Clinicopathological analysis of five cases of NUT midline carcinoma, including one with the gingiva. Biomed Res Int 2020:9791208","journal-title":"Biomed Res Int"},{"key":"3011_CR17","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1177\/1066896918796606","volume":"27","author":"R Reddy","year":"2019","unstructured":"Reddy R, Woods TR, Allan RW, Malhotra P, Mehta HJ, Sarkar PK et al (2019) NUT (nuclear protein in testis) carcinoma: a report of two cases with different histopathologic features. Int J Surg Pathol 27:225\u2013229","journal-title":"Int J Surg Pathol"},{"key":"3011_CR18","doi-asserted-by":"publisher","first-page":"280","DOI":"10.3109\/01913123.2012.664613","volume":"36","author":"EP Wartchow","year":"2012","unstructured":"Wartchow EP, Moore TS, French CA, Mierau GW (2012) Ultrastructural features of NUT midline carcinoma. Ultrastruct Pathol 36:280\u2013284","journal-title":"Ultrastruct Pathol"},{"key":"3011_CR19","doi-asserted-by":"publisher","first-page":"349","DOI":"10.4132\/jptm.2018.07.16","volume":"52","author":"T Lee","year":"2018","unstructured":"Lee T, Choi S, Han J, Choi YL, Lee K (2018) Abrupt dyskeratotic and squamoid cells in poorly differentiated carcinoma: case study of two thoracic NUT midline carcinomas with cytohistologic correlation. J Pathol Transl Med 52:349\u2013353","journal-title":"J Pathol Transl Med"},{"key":"3011_CR20","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1097\/PAS.0b013e318198d666","volume":"33","author":"H Haack","year":"2009","unstructured":"Haack H, Johnson LA, Fry CJ, Crosby K, Polakiewicz RD, Stelow EB et al (2009) Diagnosis of NUT midline carcinoma using a NUT-specific monoclonal antibody. Am J Surg Pathol 33:984\u2013991","journal-title":"Am J Surg Pathol"},{"key":"3011_CR21","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s13000-015-0395-9","volume":"10","author":"M Lund-Iversen","year":"2015","unstructured":"Lund-Iversen M, Gr\u00f8holt KK, Helland \u00c5, Borgen E, Brustugun OT (2015) NUT expression in primary lung tumours. Diagn Pathol 10:156","journal-title":"Diagn Pathol"},{"key":"3011_CR22","doi-asserted-by":"publisher","first-page":"e740","DOI":"10.1634\/theoncologist.2018-0477","volume":"24","author":"M Jung","year":"2019","unstructured":"Jung M, Kim S, Lee JK, Yoon SO, Park HS, Hong SW et al (2019) Clinicopathological and preclinical findings of NUT carcinoma: a multicenter study. Oncologist 24:e740\u2013e7e8","journal-title":"Oncologist"},{"key":"3011_CR23","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1111\/1759-7714.13438","volume":"11","author":"HJ Cho","year":"2020","unstructured":"Cho HJ, Lee HK (2020) Lung nuclear protein in testis carcinoma in an elderly Korean woman: a case report with cytohistological analysis. Thorac Cancer 11:1724\u20131727","journal-title":"Thorac Cancer"},{"key":"3011_CR24","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1080\/15384047.2018.1523852","volume":"20","author":"N Mao","year":"2019","unstructured":"Mao N, Liao Z, Wu J, Liang K, Wang S, Qin S et al (2019) Diagnosis of NUT carcinoma of lung origin by next-generation sequencing: case report and review of the literature. Cancer Biol Ther 20:150\u2013156","journal-title":"Cancer Biol Ther"},{"key":"3011_CR25","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1097\/PAS.0b013e31824230a8","volume":"36","author":"M Tanaka","year":"2012","unstructured":"Tanaka M, Kato K, Gomi K, Yoshida M, Niwa T, Aida N et al (2012) NUT midline carcinoma: report of 2 cases suggestive of pulmonary origin. Am J Surg Pathol 36:381\u2013388","journal-title":"Am J Surg Pathol"},{"key":"3011_CR26","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1097\/PAI.0b013e3182a4ef2e","volume":"22","author":"PG Salles","year":"2014","unstructured":"Salles PG, Moura Rde D, Menezes LM, Bacchi CE (2014) Expression of P16 in NUT carcinomas with no association with human papillomavirus (HPV). Appl Immunohistochem Mol Morphol 22:262\u2013265","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"3011_CR27","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1097\/PAS.0b013e31815a3900","volume":"32","author":"EB Stelow","year":"2008","unstructured":"Stelow EB, Bellizzi AM, Taneja K, Mills SE, Legallo RD, Kutok JL et al (2008) NUT rearrangement in undifferentiated carcinomas of the upper aerodigestive tract. Am J Surg Pathol 32:828\u2013834","journal-title":"Am J Surg Pathol"},{"key":"3011_CR28","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1007\/s12105-013-0479-3","volume":"8","author":"AF Mills","year":"2014","unstructured":"Mills AF, Lanfranchi M, Wein RO, Mukand-Cerro I, Pilichowska M, Cowan J et al (2014) NUT midline carcinoma: a case report with a novel translocation and review of the literature. Head Neck Pathol 8:182\u2013186","journal-title":"Head Neck Pathol"},{"key":"3011_CR29","doi-asserted-by":"publisher","first-page":"4664","DOI":"10.1038\/onc.2012.487","volume":"32","author":"K Thompson-Wicking","year":"2013","unstructured":"Thompson-Wicking K, Francis RW, Stirnweiss A, Ferrari E, Welch MD, Baker E et al (2013) Novel BRD4-NUT fusion isoforms increase the pathogenic complexity in NUT midline carcinoma. Oncogene 32:4664\u20134674","journal-title":"Oncogene"},{"key":"3011_CR30","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/1471-2407-6-69","volume":"6","author":"J Engleson","year":"2006","unstructured":"Engleson J, Soller M, Panagopoulos I, Dahl\u00e9n A, Dictor M, Jerkeman M (2006) Midline carcinoma with t(15;19) and BRD4-NUT fusion oncogene in a 30-year-old female with response to docetaxel and radiotherapy. BMC Cancer 6:69","journal-title":"BMC Cancer"},{"key":"3011_CR31","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/nrc3659","volume":"14","author":"C French","year":"2014","unstructured":"French C (2014) NUT midline carcinoma. Nat Rev Cancer 14:149\u2013150","journal-title":"Nat Rev Cancer"},{"key":"3011_CR32","doi-asserted-by":"publisher","first-page":"2943","DOI":"10.1038\/emboj.2010.176","volume":"29","author":"N Reynoird","year":"2010","unstructured":"Reynoird N, Schwartz BE, Delvecchio M, Sadoul K, Meyers D, Mukherjee C et al (2010) Oncogenesis by sequestration of CBP\/p300 in transcriptionally inactive hyperacetylated chromatin domains. EMBO J 29:2943\u20132952","journal-title":"EMBO J"},{"key":"3011_CR33","doi-asserted-by":"publisher","first-page":"2686","DOI":"10.1158\/0008-5472.CAN-10-3513","volume":"71","author":"BE Schwartz","year":"2011","unstructured":"Schwartz BE, Hofer MD, Lemieux ME, Bauer DE, Cameron MJ, West NH et al (2011) Differentiation of NUT midline carcinoma by epigenomic reprogramming. Cancer Res 71:2686\u20132696","journal-title":"Cancer Res"},{"key":"3011_CR34","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1038\/onc.2013.126","volume":"33","author":"AR Grayson","year":"2014","unstructured":"Grayson AR, Walsh EM, Cameron MJ, Godec J, Ashworth T, Ambrose JM et al (2014) MYC, a downstream target of BRD-NUT, is necessary and sufficient for the blockade of differentiation in NUT midline carcinoma. Oncogene 33:1736\u20131742","journal-title":"Oncogene"},{"key":"3011_CR35","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1136\/jcp.2007.052902","volume":"63","author":"CA French","year":"2010","unstructured":"French CA (2010) Demystified molecular pathology of NUT midline carcinomas. J Clin Pathol 63:492\u2013496","journal-title":"J Clin Pathol"},{"key":"3011_CR36","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1093\/annonc\/mdw686","volume":"28","author":"JK Lee","year":"2017","unstructured":"Lee JK, Louzada S, An Y, Kim SY, Kim S, Youk J et al (2017) Complex chromosomal rearrangements by single catastrophic pathogenesis in NUT midline carcinoma. Ann Oncol 28:890\u2013897","journal-title":"Ann Oncol"},{"key":"3011_CR37","doi-asserted-by":"publisher","first-page":"53997","DOI":"10.18632\/oncotarget.9804","volume":"7","author":"V Sahai","year":"2016","unstructured":"Sahai V, Redig AJ, Collier KA, Eckerdt FD, Munshi HG (2016) Targeting BET bromodomain proteins in solid tumors. Oncotarget 7:53997\u201354009","journal-title":"Oncotarget"},{"key":"3011_CR38","doi-asserted-by":"publisher","first-page":"e5","DOI":"10.5301\/TJ.5000685","volume":"103","author":"S Cavalieri","year":"2017","unstructured":"Cavalieri S, Stathis A, Fabbri A, Sonzogni A, Perrone F, Tamborini E et al (2017) Uncommon somatic mutations in metastatic NUT midline carcinoma. Tumori 103:e5\u2013e8","journal-title":"Tumori"},{"key":"3011_CR39","doi-asserted-by":"publisher","first-page":"e57","DOI":"10.1200\/JCO.2012.48.5300","volume":"32","author":"MM Puliyel","year":"2014","unstructured":"Puliyel MM, Mascarenhas L, Zhou S, Sapra A, Dal Cin P, French CA et al (2014) Nuclear protein in testis midline carcinoma misdiagnosed as adamantinoma. J Clin Oncol 32:e57\u2013e60","journal-title":"J Clin Oncol"},{"key":"3011_CR40","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1186\/s12885-016-2944-3","volume":"16","author":"Y Harada","year":"2016","unstructured":"Harada Y, Koyama T, Takeuchi K, Shoji K, Hoshi K, Oyama Y (2016) NUT midline carcinoma mimicking a germ cell tumor: a case report. BMC Cancer 16:895","journal-title":"BMC Cancer"},{"key":"3011_CR41","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s00428-019-02623-8","volume":"476","author":"T Goto","year":"2020","unstructured":"Goto T, Arai Y, Shibata T, Oyama T, Yoshida A (2020) Sarcoma with MGA-NUTM1 fusion in the lung: an emerging entity. Virchows Arch 476:317\u2013322","journal-title":"Virchows Arch"},{"key":"3011_CR42","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1002\/gcc.3","volume":"57","author":"IM Schaefer","year":"2018","unstructured":"Schaefer IM, Dal Cin P, Landry LM, Fletcher CDM, Hanna GJ, French CA (2018) CIC-NUTM1 fusion: a case which expands the spectrum of NUT-rearranged epithelioid malignancies. Genes Chromosom Cancer 57:446\u2013451","journal-title":"Genes Chromosom Cancer"},{"key":"3011_CR43","first-page":"560","volume":"63","author":"DN Reisman","year":"2003","unstructured":"Reisman DN, Sciarrotta J, Wang W, Funkhouser WK, Weissman BE (2003) Loss of BRG1\/BRM in human lung cancer cell lines and primary lung cancers: correlation with poor prognosis. Cancer Res 63:560\u2013566","journal-title":"Cancer Res"},{"key":"3011_CR44","first-page":"6171","volume":"60","author":"AK Wong","year":"2000","unstructured":"Wong AK, Shanahan F, Chen Y, Lian L, Ha P, Hendricks K et al (2000) BRG1, a component of the SWI-SNF complex, is mutated in multiple human tumor cell lines. Cancer Res 60:6171\u20136177","journal-title":"Cancer Res"},{"key":"3011_CR45","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1038\/ng.3399","volume":"47","author":"F Le Loarer","year":"2015","unstructured":"Le Loarer F, Watson S, Pierron G, de Montpreville VT, Ballet S, Firmin N et al (2015) SMARCA4 inactivation defines a group of undifferentiated thoracic malignancies transcriptionally related to BAF-deficient sarcomas. Nat Genet 47:1200\u20131205","journal-title":"Nat Genet"},{"key":"3011_CR46","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1136\/jclinpath-2020-206451","volume":"73","author":"R Chetty","year":"2020","unstructured":"Chetty R, Serra S (2020) SMARCA family of genes. J Clin Pathol 73:257\u2013260","journal-title":"J Clin Pathol"},{"key":"3011_CR47","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.jtho.2019.10.023","volume":"15","author":"N Rekhtman","year":"2020","unstructured":"Rekhtman N, Montecalvo J, Chang JC, Alex D, Ptashkin RN, Ai N et al (2020) SMARCA4-deficient thoracic sarcomatoid tumors represent primarily smoking-related undifferentiated carcinomas rather than primary thoracic sarcomas. J Thorac Oncol 15:231\u2013247","journal-title":"J Thorac Oncol"},{"key":"3011_CR48","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1097\/PAS.0000000000001188","volume":"43","author":"R Perret","year":"2019","unstructured":"Perret R, Chalabreysse L, Watson S, Serre I, Garcia S, Forest F et al (2019) SMARCA4-deficient thoracic sarcomas: clinicopathologic study of 30 cases with an emphasis on their nosology and differential diagnoses. Am J Surg Pathol 43:455\u2013465","journal-title":"Am J Surg Pathol"},{"key":"3011_CR49","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1002\/path.4633","volume":"238","author":"AN Karnezis","year":"2016","unstructured":"Karnezis AN, Wang Y, Ramos P, Hendricks WP, Oliva E, D'Angelo E et al (2016) Dual loss of the SWI\/SNF complex ATPases SMARCA4\/BRG1 and SMARCA2\/BRM is highly sensitive and specific for small cell carcinoma of the ovary, hypercalcaemic type. J Pathol 238:389\u2013400","journal-title":"J Pathol"},{"key":"3011_CR50","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1038\/modpathol.2017.11","volume":"30","author":"A Yoshida","year":"2017","unstructured":"Yoshida A, Kobayashi E, Kubo T, Kodaira M, Motoi T, Motoi N et al (2017) Clinicopathological and molecular characterization of SMARCA4-deficient thoracic sarcomas with comparison to potentially related entities. Mod Pathol 30:797\u2013809","journal-title":"Mod Pathol"},{"key":"3011_CR51","doi-asserted-by":"publisher","first-page":"4730","DOI":"10.1007\/s00330-019-06017-x","volume":"29","author":"A Cromb\u00e9","year":"2019","unstructured":"Cromb\u00e9 A, Alberti N, Villard N, Pilleul F, Buy X, Le Loarer F et al (2019) Imaging features of SMARCA4-deficient thoracic sarcomas: a multi-centric study of 21 patients. Eur Radiol 29:4730\u20134741","journal-title":"Eur Radiol"},{"key":"3011_CR52","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1038\/modpathol.2017.61","volume":"30","author":"JL Sauter","year":"2017","unstructured":"Sauter JL, Graham RP, Larsen BT, Jenkins SM, Roden AC, Boland JM (2017) SMARCA4-deficient thoracic sarcoma: a distinctive clinicopathological entity with undifferentiated rhabdoid morphology and aggressive behavior. Mod Pathol 30:1422\u20131432","journal-title":"Mod Pathol"},{"key":"3011_CR53","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.lungcan.2019.10.009","volume":"138","author":"T Naito","year":"2019","unstructured":"Naito T, Udagawa H, Umemura S, Sakai T, Zenke Y, Kirita K et al (2019) Non-small cell lung cancer with loss of expression of the SWI\/SNF complex is associated with aggressive clinicopathological features, PD-L1-positive status, and high tumor mutation burden. Lung Cancer 138:35\u201342","journal-title":"Lung Cancer"},{"key":"3011_CR54","doi-asserted-by":"publisher","first-page":"563","DOI":"10.2217\/imt-2019-0142","volume":"12","author":"Y Iijima","year":"2020","unstructured":"Iijima Y, Sakakibara R, Ishizuka M, Honda T, Shirai T, Okamoto T et al (2020) Notable response to nivolumab during the treatment of SMARCA4-deficient thoracic sarcoma: a case report. Immunotherapy 12:563\u2013569","journal-title":"Immunotherapy"},{"key":"3011_CR55","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1093\/annonc\/mdz160","volume":"30","author":"C Henon","year":"2019","unstructured":"Henon C, Blay JY, Massard C, Mir O, Bahleda R, Dumont S et al (2019) Long lasting major response to pembrolizumab in a thoracic malignant rhabdoid-like SMARCA4-deficient tumor. Ann Oncol 30:1401\u20131403","journal-title":"Ann Oncol"},{"key":"3011_CR56","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.1111\/1759-7714.13215","volume":"10","author":"K Takada","year":"2019","unstructured":"Takada K, Sugita S, Murase K, Kikuchi T, Oomori G, Ito R et al (2019) Exceptionally rapid response to pembrolizumab in a SMARCA4-deficient thoracic sarcoma overexpressing PD-L1: a case report. Thorac Cancer 10:2312\u20132315","journal-title":"Thorac Cancer"},{"key":"3011_CR57","doi-asserted-by":"publisher","unstructured":"Schoenfeld AJ, Bandlamudi C, Lavery JA, Montecalvo J, Namakydoust A, Rizvi H et al (2020) The genomic landscape of SMARCA4 alterations and associations with outcomes in patients with lung cancer. Clin Cancer Res. https:\/\/doi.org\/10.1158\/1078-0432.CCR-20-1825","DOI":"10.1158\/1078-0432.CCR-20-1825"},{"key":"3011_CR58","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.1158\/1078-0432.CCR-15-1468","volume":"22","author":"EH Bell","year":"2016","unstructured":"Bell EH, Chakraborty AR, Mo X, Liu Z, Shilo K, Kirste S et al (2016) SMARCA4\/BRG1 Is a novel prognostic biomarker predictive of cisplatin-based chemotherapy outcomes in resected non-small cell lung cancer. Clin Cancer Res 22:2396\u20132404","journal-title":"Clin Cancer Res"},{"key":"3011_CR59","doi-asserted-by":"publisher","first-page":"2761","DOI":"10.1158\/0008-5472.CAN-18-1545","volume":"79","author":"T Shorstova","year":"2019","unstructured":"Shorstova T, Marques M, Su J, Johnston J, Kleinman CL, Hamel N et al (2019) SWI\/SNF-Compromised cancers are susceptible to bromodomain inhibitors. Cancer Res 79:2761\u20132774","journal-title":"Cancer Res"},{"key":"3011_CR60","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1159\/000493335","volume":"62","author":"M Matsushita","year":"2018","unstructured":"Matsushita M, Kuwamoto S (2018) Cytologic features of SMARCA4-deficient thoracic sarcoma: a case report and comparison with other SWI\/SNF complex-deficient tumors. Acta Cytol 62:456\u2013462","journal-title":"Acta Cytol"},{"key":"3011_CR61","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.annpat.2019.05.001","volume":"39","author":"M Le Quang","year":"2019","unstructured":"Le Quang M, Ranch\u00e8re-Vince D, Le Loarer F (2019) Pathological and molecular features of malignancies underlined by BAF complexes inactivation. Ann Pathol 39:399\u2013413","journal-title":"Ann Pathol"},{"key":"3011_CR62","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1111\/cas.12065","volume":"104","author":"D Matsubara","year":"2013","unstructured":"Matsubara D, Kishaba Y, Ishikawa S, Sakatani T, Oguni S, Tamura T et al (2013) Lung cancer with loss of BRG1\/BRM, shows epithelial mesenchymal transition phenotype and distinct histologic and genetic features. Cancer Sci 104:266\u2013273","journal-title":"Cancer Sci"},{"key":"3011_CR63","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.anndiagpath.2016.10.006","volume":"26","author":"E Herpel","year":"2017","unstructured":"Herpel E, Rieker RJ, Dienemann H, Muley T, Meister M, Hartmann A et al (2017) SMARCA4 and SMARCA2 deficiency in non-small cell lung cancer: immunohistochemical survey of 316 consecutive specimens. Ann Diagn Pathol 26:47\u201351","journal-title":"Ann Diagn Pathol"},{"key":"3011_CR64","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s00428-017-2148-5","volume":"471","author":"A Agaimy","year":"2017","unstructured":"Agaimy A, Fuchs F, Moskalev EA, Sirbu H, Hartmann A, Haller F (2017) SMARCA4-deficient pulmonary adenocarcinoma: clinicopathological, immunohistochemical, and molecular characteristics of a novel aggressive neoplasm with a consistent TTF1(neg)\/CK7(pos)\/HepPar-1(pos) immunophenotype. Virchows Arch 471:599\u2013609","journal-title":"Virchows Arch"},{"key":"3011_CR65","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.stemcr.2014.07.004","volume":"3","author":"X Zhang","year":"2014","unstructured":"Zhang X, Li B, Li W, Ma L, Zheng D, Li L et al (2014) Transcriptional repression by the BRG1-SWI\/SNF complex affects the pluripotency of human embryonic stem cells. Stem Cell Rep 3:460\u2013474","journal-title":"Stem Cell Rep"},{"key":"3011_CR66","doi-asserted-by":"publisher","first-page":"6486","DOI":"10.1158\/0008-5472.CAN-14-0061","volume":"74","author":"T Orvis","year":"2014","unstructured":"Orvis T, Hepperla A, Walter V, Song S, Simon J, Parker J et al (2014) BRG1\/SMARCA4 inactivation promotes non-small cell lung cancer aggressiveness by altering chromatin organization. Cancer Res 74:6486\u20136498","journal-title":"Cancer Res"},{"key":"3011_CR67","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1002\/emmm.201200236","volume":"4","author":"OA Romero","year":"2012","unstructured":"Romero OA, Setien F, John S, Gimenez-Xavier P, G\u00f3mez-L\u00f3pez G, Pisano D et al (2012) The tumour suppressor and chromatin-remodelling factor BRG1 antagonizes Myc activity and promotes cell differentiation in human cancer. EMBO Mol Med 4:603\u2013616","journal-title":"EMBO Mol Med"},{"key":"3011_CR68","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1128\/MCB.24.3.1188-1199.2004","volume":"24","author":"H Kang","year":"2004","unstructured":"Kang H, Cui K, Zhao K (2004) BRG1 controls the activity of the retinoblastoma protein via regulation of p21CIP1\/WAF1\/SDI. Mol Cell Biol 24:1188\u20131199","journal-title":"Mol Cell Biol"},{"key":"3011_CR69","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1038\/s41591-018-0019-5","volume":"24","author":"Y Lissanu Deribe","year":"2018","unstructured":"Lissanu Deribe Y, Sun Y, Terranova C, Khan F, Martinez-Ledesma J, Gay J et al (2018) Mutations in the SWI\/SNF complex induce a targetable dependence on oxidative phosphorylation in lung cancer. Nat Med 24:1047\u20131057","journal-title":"Nat Med"},{"key":"3011_CR70","volume-title":"GeneReviews(\u00ae)","author":"K Nemes","year":"2017","unstructured":"Nemes K, Bens S, Bourdeaut F, Hasselblatt M, Kool M, Johann P et al (2017) Rhabdoid tumor predisposition syndrome. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K et al (eds) GeneReviews(\u00ae). University of Washington, Seattle, Seattle"},{"key":"3011_CR71","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.1056\/NEJMc1803354","volume":"378","author":"L de Kock","year":"2018","unstructured":"de Kock L, Fahiminiya S, Fiset PO, Astigarraga I, Nguyen VH, Albrecht S et al (2018) Infantile pulmonary teratoid tumor. N Engl J Med 378:2238\u20132240","journal-title":"N Engl J Med"},{"key":"3011_CR72","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.jtho.2020.01.002","volume":"15","author":"I Dagogo-Jack","year":"2020","unstructured":"Dagogo-Jack I, Schrock AB, Kem M, Jessop N, Lee J, Ali SM et al (2020) Clinicopathologic characteristics of BRG1-deficient NSCLC. J Thorac Oncol 15:766\u2013776","journal-title":"J Thorac Oncol"},{"key":"3011_CR73","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1093\/hmg\/ddu554","volume":"24","author":"IF Coira","year":"2015","unstructured":"Coira IF, Rufino-Palomares EE, Romero OA, Peinado P, Metheetrairut C, Boyero-Corral L et al (2015) Expression inactivation of SMARCA4 by microRNAs in lung tumors. Hum Mol Genet 24:1400\u20131409","journal-title":"Hum Mol Genet"},{"key":"3011_CR74","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.humpath.2017.05.024","volume":"70","author":"S Kuwamoto","year":"2017","unstructured":"Kuwamoto S, Matsushita M, Takeda K, Tanaka N, Endo Y, Yamasaki A et al (2017) SMARCA4-deficient thoracic sarcoma: report of a case and insights into how to reach the diagnosis using limited samples and resources. Hum Pathol 70:92\u201397","journal-title":"Hum Pathol"},{"key":"3011_CR75","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1097\/PAS.0000000000001262","volume":"43","author":"MS Ahadi","year":"2019","unstructured":"Ahadi MS, Gill AJ (2019) SMARCA4 loss is very rare in thoracic mesothelioma. Am J Surg Pathol 43:1154\u20131155","journal-title":"Am J Surg Pathol"},{"key":"3011_CR76","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1097\/PAS.0b013e318254ce54","volume":"36","author":"JA Bishop","year":"2012","unstructured":"Bishop JA, Westra WH (2012) Nut midline carcinomas of the sinonasal tract. Am J Surg Pathol 36:1216\u20131221","journal-title":"Am J Surg Pathol"},{"key":"3011_CR77","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1007\/s12105-017-0858-2","volume":"12","author":"A Kakkar","year":"2018","unstructured":"Kakkar A, Antony VM, Irugu DVK, Adhikari N, Jain D (2018) NUT midline carcinoma: a series of five cases, including one with unusual clinical course. Head Neck Pathol 12:230\u2013236","journal-title":"Head Neck Pathol"},{"key":"3011_CR78","doi-asserted-by":"publisher","unstructured":"Hung YP, Chen AL, Taylor MS, Huynh TG, Kem M, Selig MK et al (2020) Thoracic NUT carcinoma: expanded pathologic spectrum with expression of TTF-1 and neuroendocrine markers. Histopathology. https:\/\/doi.org\/10.1111\/his.14306","DOI":"10.1111\/his.14306"},{"key":"3011_CR79","doi-asserted-by":"publisher","unstructured":"Russell-Goldman E, Hornick JL, Hanna J (2020) Utility of YAP1 and NUT immunohistochemistry in the diagnosis of porocarcinoma. J Cutan Pathol. https:\/\/doi.org\/10.1111\/cup.13924","DOI":"10.1111\/cup.13924"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-020-03011-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00428-020-03011-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-020-03011-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,18]],"date-time":"2022-04-18T03:36:54Z","timestamp":1650253014000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00428-020-03011-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":79,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["3011"],"URL":"https:\/\/doi.org\/10.1007\/s00428-020-03011-3","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"24 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"This review was performed in compliance with medical ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors have no conflicts of interest to disclose","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}